Aqr Capital Management LLC Fibrogen Inc Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.89 - $2.36 $684,931 - $1.82 Million
769,586 Added 139.6%
1,320,866 $1.18 Million
Q1 2024

May 15, 2024
SELL
$0.73 - $2.73 $448,206 - $1.68 Million
-613,981 Reduced 52.69%
551,280 $1.3 Million
Q4 2023

Feb 14, 2024
BUY
$0.38 - $0.91 $114,561 - $274,344
301,478 Added 34.9%
1,165,261 $1.04 Million
Q3 2023

Nov 14, 2023
BUY
$0.79 - $2.83 $619,265 - $2.22 Million
783,881 Added 981.05%
863,783 $742,000
Q2 2023

Aug 14, 2023
BUY
$2.49 - $20.59 $156,683 - $1.3 Million
62,925 Added 370.65%
79,902 $215,000
Q1 2023

May 15, 2023
BUY
$15.95 - $25.18 $270,783 - $427,480
16,977 New
16,977 $316,000
Q3 2022

Nov 14, 2022
BUY
$11.4 - $14.6 $459,032 - $587,883
40,266 New
40,266 $524,000
Q2 2022

Aug 15, 2022
SELL
$7.94 - $12.96 $597,723 - $975,628
-75,280 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$12.02 - $16.79 $904,865 - $1.26 Million
75,280 New
75,280 $905,000
Q4 2021

Feb 14, 2022
SELL
$9.93 - $15.39 $765,404 - $1.19 Million
-77,080 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$10.18 - $26.64 $784,674 - $2.05 Million
77,080 New
77,080 $788,000
Q1 2021

May 17, 2021
SELL
$31.0 - $55.72 $265,825 - $477,799
-8,575 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$37.09 - $48.97 $220,796 - $291,518
-5,953 Reduced 40.98%
8,575 $318,000
Q3 2020

Nov 16, 2020
SELL
$40.47 - $45.5 $1.58 Million - $1.78 Million
-39,093 Reduced 72.91%
14,528 $597,000
Q2 2020

Aug 17, 2020
SELL
$32.57 - $42.83 $639,186 - $840,538
-19,625 Reduced 26.79%
53,621 $2.17 Million
Q1 2020

May 15, 2020
SELL
$23.3 - $45.96 $553,258 - $1.09 Million
-23,745 Reduced 24.48%
73,246 $2.55 Million
Q4 2019

Feb 14, 2020
BUY
$34.58 - $48.06 $2.78 Million - $3.86 Million
80,420 Added 485.31%
96,991 $4.16 Million
Q3 2019

Nov 14, 2019
SELL
$36.98 - $48.45 $12,277 - $16,085
-332 Reduced 1.96%
16,571 $613,000
Q2 2019

Aug 14, 2019
BUY
$35.13 - $55.53 $383,514 - $606,221
10,917 Added 182.38%
16,903 $764,000
Q1 2019

May 14, 2019
SELL
$42.83 - $59.91 $85,060 - $118,981
-1,986 Reduced 24.91%
5,986 $325,000
Q4 2018

Feb 14, 2019
SELL
$37.97 - $60.16 $1.38 Million - $2.19 Million
-36,357 Reduced 82.02%
7,972 $369,000
Q3 2018

Nov 15, 2018
SELL
$56.3 - $67.25 $1.26 Million - $1.5 Million
-22,376 Reduced 33.54%
44,329 $2.69 Million
Q2 2018

Aug 14, 2018
SELL
$44.9 - $64.95 $2.72 Million - $3.94 Million
-60,621 Reduced 47.61%
66,705 $4.18 Million
Q1 2018

May 15, 2018
SELL
$45.35 - $61.65 $1.85 Million - $2.51 Million
-40,767 Reduced 24.25%
127,326 $5.88 Million
Q4 2017

Feb 14, 2018
BUY
$41.95 - $60.1 $406,159 - $581,888
9,682 Added 6.11%
168,093 $7.97 Million
Q3 2017

Nov 14, 2017
BUY
$33.4 - $53.9 $5.29 Million - $8.54 Million
158,411
158,411 $8.52 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email